Terbinafin Axapharm 250 mg, Tabletten

7680584520038 CH-58452 Tabletten

Associated product:

TERBINAFINE Axapharm cpr 250 mg 14 pce
Terbinafin Axapharm 250 mg, Tabletten
Terbinafin Axapharm 250 mg, Tabletten
Terbinafin Axapharm 250 mg, Tabletten
1 / 3
google

Article details

Package size
14
Selling units
14
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/06/2022
Patient information leaflet
Français
14/06/2022
Patient information leaflet
Italien
14/06/2022
Summary of Product Characteristics
Allemand
14/06/2022
Summary of Product Characteristics
Français
14/06/2022
Summary of Product Characteristics
Italien
14/06/2022

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.64 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 43.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/11/2007

Authorization holder

axapharm ag

6340 Baar

Authorization information

Swissmedic authorization number
58452
Drug name
Terbinafin Axapharm, Tabletten
Galenic form
TAB
ATC Code
D01BA02
Authorization status
Z
Authorization category
Category C
Dispensing category
B
First authorization
02/08/2007
Authorization expiration date
31/12/9999
IT Number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Package details

Description (FR)
TERBINAFINE Axapharm cpr 250 mg 14 pce
Description (DE)
TERBINAFIN Axapharm Tabl 250 mg 14 Stk
Market launch
02/08/2007
Narcotic (BTM)
No

Original drug

Lamisil, Tabletten
GTIN: 7680513060314
CHF 39.75
View original

Other package sizes (2)

None
14 TABL
GTIN: None
Not in V1
TERBINAFINE Axapharm cpr 250 mg 28 pce
28 TABL
GTIN: 7680584520052
View